It may take inflammation, phosphorylation and ubiquitination to "tangle' in Alzheimer's disease

被引:78
作者
Arnaud, Lisette
Robakis, Nikolaos K.
Figueiredo-Pereira, Maria E.
机构
[1] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA
[2] CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA
关键词
neurofibrillary tangles; ubiquitinated; Alzheimer's disease; neuroinflammation; early stages;
D O I
10.1159/000095638
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibrillary tangles (NFT) are one of the pathologic hallmarks of Alzheimer's disease (AD). Their major component is tau, a protein that becomes hyperphosphorylated and accumulates into insoluble paired helical filaments. During the course of the disease such filaments aggregate into bulky NFT that get ubiquitinated. What triggers their formation is not known, but neuroinflammation could play a role. Neuroinflammation is an active process detectable in the earliest stages of AD. The neuronal toxicity associated with inflammation makes it a potential risk factor in the pathogenesis of chronic neurodegenerative diseases, such as AD. Determining the sequence of events that lead to this devastating disease has become one of the most important goals for AD prevention and treatment. In this review we focus on three topics relevant to AD pathology and to NFT formation: (1) what triggers CNS inflammation resulting in glia activation and neuronal toxicity; (2) how products of inflammation might change the substrate specificity of kinases/phosphatases leading to tau phosphorylation at pathological sites; (3)the relationship between the ubiquitin/proteasome pathway and tau ubiquitination and accumulation in NFT. The overall aim of this review is to provide a challenging and sometimes provocative survey of important contributions supporting the view that CNS inflammation might be a critical contributor to AD pathology. Neuronal cell death resulting from neuroinflammatory processes may have devastating effects as, in the vast majority of cases, neurons lost to disease cannot be replaced. In order to design therapies that will prevent endangered neurons from dying, it is critical that we learn more about the effects of neuroinflammation and its products. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 74 条
[1]   Prostaglandin EN receptor agonist protects against acute neurotoxicity [J].
Ahmad, AS ;
Ahmad, M ;
de Brum-Fernandes, AJ ;
Doré, S .
BRAIN RESEARCH, 2005, 1066 (1-2) :71-77
[2]   Inflammation in central nervous system injury [J].
Allan, SM ;
Rothwell, NJ .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 358 (1438) :1669-1677
[3]   Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease [J].
Augustinack, JC ;
Schneider, A ;
Mandelkow, EM ;
Hyman, BT .
ACTA NEUROPATHOLOGICA, 2002, 103 (01) :26-35
[4]   Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation [J].
Babu, JR ;
Geetha, T ;
Wooten, MW .
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (01) :192-203
[5]   Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function [J].
Barger, SW ;
Basile, AS .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (03) :846-854
[6]   Prostaglandin D2 mediates neuronal damage by amyloid-β or prions which activates microglial cells [J].
Bate, C ;
Kempster, S ;
Williams, A .
NEUROPHARMACOLOGY, 2006, 50 (02) :229-237
[7]   Microglia kill amyloid-β1-42 damaged neurons by a CD14-dependent process [J].
Bate, C ;
Veerhuis, R ;
Eikelenboom, P ;
Williarns, A .
NEUROREPORT, 2004, 15 (09) :1427-1430
[8]  
Brown MR, 2005, J ALZHEIMERS DIS, V7, P15
[9]   Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway [J].
Cardozo, C ;
Michaud, C .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 408 (01) :103-110
[10]   Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons [J].
Chen, C ;
Bazan, NG .
JOURNAL OF NEUROPHYSIOLOGY, 2005, 93 (02) :929-941